sábado, 22 de julio de 2017

Scrub Typhus as a Cause of Acute Encephalitis Syndrome, Gorakhpur, Uttar Pradesh, India - Volume 23, Number 8—August 2017 - Emerging Infectious Disease journal - CDC

Scrub Typhus as a Cause of Acute Encephalitis Syndrome, Gorakhpur, Uttar Pradesh, India - Volume 23, Number 8—August 2017 - Emerging Infectious Disease journal - CDC

Volume 23, Number 8—August 2017

Research Letter

Scrub Typhus as a Cause of Acute Encephalitis Syndrome, Gorakhpur, Uttar Pradesh, India

Mahima Mittal, Jeromie Wesley Vivian Thangaraj, Winsley Rose, Valsan Philip Verghese, C.P. Girish Kumar, Mahim Mittal, R. Sabarinathan, Vijay Bondre, Nivedita Gupta, and Manoj V. MurhekarComments to Author 
Author affiliations: BRD Medical College, Gorakhpur, India (Mahima Mittal, Mahim Mittal)National Institute of Epidemiology, Chennai, India (J.W.V. Thangaraj, C.P. Girish Kumar, R. Sabarinathan, M.V. Murhekar)Christian Medical College, Vellore, India (W. Rose, V.P. Verghese)National Institute of Virology, Gorakhpur (V. Bondre)Indian Council of Medical Research, Delhi, India (N. Gupta)


Outbreaks of acute encephalitis syndrome (AES) have been occurring in Gorakhpur Division, Uttar Pradesh, India, for several years. In 2016, we conducted a case–control study. Our findings revealed a high proportion of AES cases with Orientia tsutsugamushi IgM and IgG, indicating that scrub typhus is a cause of AES.
Outbreaks of acute encephalitis syndrome (AES) with high case-fatality rates have been occurring in Gorakhpur Division of Uttar Pradesh, India, since 1978 (1). AES predominantly affects children <15 years of age (2), and its etiology has remained largely unknown (3,4). Studies focusing on AES in the region have documented that cases with unknown etiology accounted for 41.6% of cases in 2011–2012 (5) and 59% in 2013–2014 (6).
Investigations conducted during the 2015 outbreak revealed scrub typhus IgM in >60% of AES cases (7). The absence of information about IgM positivity from the general population, and the probability of high background antibody levels in areas to which scrub typhus is endemic, led us to conduct an unmatched case–control study in which we compared IgM and IgG seropositivity for Orientia tsutsugamushi, the causative agent of scrub typhus, in AES patients and healthy controls.
We conducted the study during August 17–October 16, 2016. Children <15 years of age with AES admitted to the BRD Medical College in Gorakhpur during the study period were recruited to the study if their parents consented to a blood draw and they had siblings <15 years of age. We defined a case of AES as an acute onset of fever and change in mental status or new onset seizures, excluding febrile seizures (8), with cerebrospinal fluid pleocytosis (cell counts >5/mm3). Controls were healthy children <15 years of age residing in the home (sibling controls) or village (community controls) of AES case-patients. We interviewed mothers and caretakers for information on case-patients and controls.
We collected 2-mL blood samples from case-patients and controls and tested the samples for O. tsutsugamushi IgM and IgG using commercial ELISAs (Scrub Typhus Detect; InBios International Inc., Seattle, WA, USA). We considered an optical density value >0.5 to be a positive result (9). We compared IgM and IgG positivity among AES case-patients and their controls by calculating crude and adjusted odds ratios (ORs) with 95% CIs.
We enrolled 46 case-patients and 151 controls (69 sibling and 82 community controls) in the study. The median age was 5 (interquartile range 3–9) years for patients and 7 (interquartile range 4–10) years for controls. The case-patients and controls did not differ by age group or sex (Table). The mothers of 54 (35.8%) of the control children reported a history of fever in the past 6 months.
Common symptoms among the 46 AES case-patients included seizures (69.6%), altered sensorium (52.2%), and vomiting (37%); physical examinations revealed hepatomegaly (43.4%), cervical or inguinal lymphadenopathy (39.1%), and periorbital edema (54.3%). Cerebrospinal fluid was clear in appearance in 43 of the patients we tested. Cell counts ranged from 5–100/mm3 in 41 (95.3%) and were >100/mm3 in 2 patients. Protein levels in fluid were <45 mg/dL in 8 patients, 46–100 mg/dL in 15, and >100 mg/dL in 20 patients. All AES case-patients were given intravenous azithromycin; 20 patients also received injected ceftriaxone. Eight patients died.
O. tsutsugamushi IgM was detected in 29 (63%) case-patients and IgG in 38 (82.6%). For controls, IgM was detected in 7 (4.6%) and IgG in 64 (42.4%) children. Of the 8 fatal cases, 6 patients had O. tsutsugamushi IgM and all had IgG. The distribution of optical density values for IgM and IgG among cases and controls are shown in the Appendix (Technical Appendix[PDF - 94 KB - 1 page]). Twenty-eight of the 29 IgM-positive cases and 6 of the 7 controls with IgM seroreactivity were also positive for IgG. Of the 7 controls with IgM seroreactivity, 3 had a history of febrile illness in the past 6 months.
The odds of IgM scrub typhus positivity were 35.1 (95% CI 13.4–92.3) times higher among AES case-patients than among controls; when adjusted for age, the odds were 29.9 (95% CI 9.6–92.9) times higher for case-patients. The odds of IgG positivity were 6.5 (2.8–14.8) times higher among AES case-patients than controls, and when adjusted for age, the odds were 3.8 (95% CI 1.4–10.9) times higher for case-patients. When analyzed separately, AES case-patients had higher odds for IgM positivity compared with sibling (OR 25.1, 95% 6.3–99.8) or community (OR 13.2, 95% 2.27–76.7) controls.
Our study had 1 main limitation: patients and controls were selected from the same village and shared the same environmental risk factors. Despite overmatching that underestimates the strength of association, the odds ratios for O. tsutsugamushi IgM and IgG positivity were significant. We concluded that the presence of higher levels of O. tsutsugamushi IgM and IgG among AES case-patients than among controls indicates a role for scrub typhus in the etiology of AES in Gorakhpur.
Dr. Mittal is the head of the Department of Pediatrics at BRD Medical College, Gorakhpur, India. Her research interests include central nervous system infections among children.


We thank the members of the expert group on Research-Cum-Intervention project on AES/JE for their inputs on the study findings. We are grateful to Anita Mehta, S.K. Srivastava, and Bhoopendra Sharma for their cooperation. Thanks are also due to Mr. Karunakaran and Mr. Magesh for their technical support.
The study was funded from an extramural grant by the Indian Council of Medical Research, New Delhi.


  1. Mittal MKushwaha KPAES: Clinical presentation and dilemmas in critical care management. J Commun Dis2014;46:506.
  2. Ranjan PGore MSelvaraju SKushwaha KPSrivastava DKMurhekar MChanges in acute encephalitis syndrome incidence after introduction of Japanese encephalitis vaccine in a region of India. J Infect2014;69:2002DOIPubMed
  3. Bhatt GCBondre VPSapkal GNSharma TKumar SGore MMet al. Changing clinico-laboratory profile of encephalitis patients in the eastern Uttar Pradesh region of India. Trop Doct 2012;42:106e8. http://journals.sagepub.com/doi/pdf/10.1258/td.2011.110391
  4. Joshi RKalantri SPReingold AColford JM JrChanging landscape of acute encephalitis syndrome in India: a systematic review. Natl Med J India2012;25:21220.PubMed
  5. Jain PJain AKumar APrakash SKhan DNSingh KPet al. Epidemiology and etiology of acute encephalitis syndrome in North India. Jpn J Infect Dis2014;67:197203DOIPubMed
  6. Gupta SShahi RKNigam PClinico-etiological profile and predictors of outcome in acute encephalitis syndrome in adults. International Journal of Scientific Study. 2016;3:7883 http://www.ijss-sn.com/uploads/2/0/1/5/20153321/ijss_feb_oa16_2016.pdf.
  7. Murhekar MVMittal MPrakash JAPillai VMMittal MGirish Kumar CPet al. Acute encephalitis syndrome in Gorakhpur, Uttar Pradesh, India - Role of scrub typhus. J Infect2016;73:6236DOIPubMed
  8. World Health Organization. Acute Encephalitis Syndrome. Japanese encephalitis surveillance standards. January 2006. From WHO-recommended standards for surveillance of selected vaccine-preventable diseases. WHO/V&B/03.01 [cited 2016 Oct 14]. http://apps.who.int/iris/bitstream/10665/68334/1/WHO_V-B_03.01_eng.pdf
  9. Blacksell SDTanganuchitcharnchai ANawtaisong PKantipong PLaongnualpanich ADay NPet al. Diagnostic accuracy of the InBios scrub typhus detect enzyme-linked immunoassay for the detection of IgM antibodies in northern Thailand. Clin Vaccine Immunol2015;23:14854DOIPubMed


Technical Appendix

Cite This Article

DOI: 10.3201/eid2308.170025

No hay comentarios:

Publicar un comentario